Evidence map›Paper›PMID 32954656›Full record

ArticleJournal of cellular and molecular medicine2020

C-Cbl regulates c-MPL receptor trafficking and its internalization.

Melanie Märklin, Claudia Tandler, Hans-Georg Kopp, Kyle L Hoehn, Leticia Quintanilla-Martinez, Oliver Borst, Martin R Müller, Sebastian J Saur

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. GPIbα is the driving force of hepatic thrombopoietin generation.Research and practice in thrombosis and haemostasis · 2021
    Article
  8. C-Cbl regulates c-MPL receptor trafficking and its internalization.Journal of cellular and molecular medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Melanie MärklinClinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), University Hospital Tübingen, Tübingen, Germany.ORCID 0000-0002-2920-3894
Claudia TandlerClinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), University Hospital Tübingen, Tübingen, Germany.
Hans-Georg KoppDepartment of Molecular Oncology and Thoracic Oncology, Robert-Bosch-Hospital Stuttgart, Stuttgart, Germany.
Kyle L HoehnSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.
Leticia Quintanilla-MartinezDepartment of Pathology, University of Tübingen, Tübingen, Germany.
Oliver BorstDepartment of Kardiology and Angiology, University Hospital Tübingen, Tübingen, Germany.
Martin R MüllerDepartment of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
Sebastian J SaurDepartment of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
German Cancer Research Center · DEUniversity Children's Hospital Tübingen · DEKlinikum Region Hannover · DERobert Bosch Hospital · DEUniversity of Tübingen · DEUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thrombocyte formation from megakaryocyte and their progenitor cells is tightly regulated by thrombopoietin (TPO) and its receptor c-MPL, thereby maintaining physiological functionality and numbers of circulating platelets. In patients, dysfunction of this regulation could cause thrombocytopenia or myeloproliferative syndromes. Since regulation of this pathway is still not completely understood, we investigated the role of the ubiquitin ligase c-Cbl which was previously shown to negatively regulated c-MPL signalling. We developed a new conditional mouse model using c-Cbl

Indexed as

EndocytosisAnimalsIntegrasesLymphocytosisMegakaryocytesMice, Inbred C57BLMice, KnockoutProtein TransportProto-Oncogene Proteins c-cblReceptors, ThrombopoietinSignal TransductionThrombocytosisThrombopoiesisThrombopoietinCre recombinaseIntegrasesMpl protein, mouseProto-Oncogene Proteins c-cblReceptors, ThrombopoietinThrombopoietinC-Cblc-MPLmegakaryocytesplateletsthrombocytosis

Identifiers

PMID32954656
PMCPMC7687000
OpenAlexW3087431457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.